| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AMARIN CORP PLC\UK | Director | Stock Option (Right to Buy) | 116K | $125K | $1.08 | Jun 27, 2022 | Direct |
| ImmunoGen, Inc. | Director | Deferred Share Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
| ImmunoGen, Inc. | Director | Restricted Stock Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
| AMARIN CORP PLC\UK | Director | Restricted Stock Units | 93.8K | Jun 27, 2022 | Direct | ||
| Immunocore Holdings plc | Director | Share Option (Right to Buy) | 26.2K | May 15, 2025 | Direct | ||
| ENANTA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 15.7K | Mar 13, 2025 | Direct | ||
| ArriVent BioPharma, Inc. | Director | Non-Qualified Stock Option (right to buy) | 15.5K | Jun 18, 2025 | Direct | ||
| ImmunoGen, Inc. | Director | Common Stock | 0 | $29.64 | Nov 30, 2023 | Direct | |
| ImmunoGen, Inc. | Director | Stock Option (Right to Buy) | 0 | $5.19 | Feb 12, 2024 | Direct | |
| Paratek Pharmaceuticals, Inc. | Director | Common Stock | 0 | $2.20 | Sep 21, 2023 | Direct | |
| Paratek Pharmaceuticals, Inc. | Director | Stock option (right to buy) | 0 | Sep 21, 2023 | Direct |